...
首页> 外文期刊>Medicine. >Risk interrelationship among multiple primary tumors: A case report and review of literature
【24h】

Risk interrelationship among multiple primary tumors: A case report and review of literature

机译:多个原发肿瘤之间的风险相互关系:一例病例报告并文献复习

获取原文
           

摘要

Rationale: Along with advanced management in oncology, great progress has been recently achieved in the studies of multiple primary tumors . Several reports have studied the coexistence between lymphoma and either renal cell carcinoma (RCC) or Warthin tumor . However, the level of coexistence between these cases remains unclear due to the absence of a distinct link between them. Patient concerns: We present a unique case of multiple primary tumors ( lymphoma , RCC, and Warthin tumor ) in an 80-year-old man and a review of the literature on the coexistence of RCC with lymphoma and lymphoma with Warthin tumor . Diagnosis: With a history of RCC, the patient had a freely movable lump under his left ear, and the pathological report indicated Hodgkin lymphoma and Warthin tumor . Intervention: RCC and Warthin tumor of the patient were surgically treated, followed by 2 cycles (14 days per cycle) of Epirubicin 40 mg day 1, Bleomycin 8 mg day 1, Vincristine 2 mg day 1, and Dacarbazine 500 mg day 1. The chemotherapy protocol was then changed to Epirubicin 40 mg day 1, Vincristine 2 mg day 1, and Dacarbazine 500 mg day 1 for 7 cycles. Outcomes: After the last day of chemotherapy, the patient showed a complete response. Lessons: To the best of our knowledge, this paper is the first to report a case of multiple primary tumors with a complete response. For their early detection, favorable prognosis, and correlation identification, we suggest a transitive relation between these coexisting tumors. Therefore, similar studies should be conducted.
机译:基本原理:随着肿瘤学的先进管理,最近在多原发肿瘤的研究中取得了巨大的进步。一些报告研究了淋巴瘤与肾细胞癌(RCC)或Warthin肿瘤的共存。但是,由于这些案例之间没有明显的联系,因此它们之间的共存程度仍然不清楚。患者关注:我们介绍了一个80岁男性多发性原发性肿瘤(淋巴瘤,RCC和Warthin肿瘤)的独特病例,并回顾了RCC与淋巴瘤并存以及淋巴瘤与Warthin肿瘤并存的文献。诊断:有RCC病史,患者左耳下方有可自由移动的肿块,病理报告显示霍奇金淋巴瘤和沃辛瘤。干预:对患者的RCC和Warthin肿瘤进行了手术治疗,随后2个周期(每个周期14天)的表柔比星40 mg第1天,博来霉素8 mg第1天,长春新碱2 mg第1天和达卡巴嗪500 mg第1天。然后将化疗方案更改为表柔比星40 mg第1天,长春新碱2 mg第1天和达卡巴嗪500 mg第1天,共7个周期。结果:化疗最后一天后,患者显示出完全缓解。经验教训:就我们所知,本文是第一篇报道多例原发性肿瘤且反应完全的病例。对于它们的早期发现,有利的预后和相关性鉴定,我们建议这些并存肿瘤之间存在传递关系。因此,应该进行类似的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号